Part D Gap Rebates Boost Medicare Rx Spending To 9% Gain In 2010
This article was originally published in The Pink Sheet Daily
Drug spending by the Medicare program increased more than by Medicaid or by private payers in 2010, according to an analysis by CMS; expenditures in Medicaid and by private insurance were level with the previous year and consumer out-of-pocket spending declined. Total drug spending across-the-board rose 1.2% to $259 billion.
You may also be interested in...
Updates on Medicare’s ACO program, drug spending trends and Medicare coverage of IVIG.
Prices for retail drugs across US payers decreased for the first time in years, driven by a drop in generic prices and “little to no growth” in prices for brands.